{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:00:20Z","timestamp":1781168420570,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.compbiomed.2025.111343","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:48:06Z","timestamp":1764164886000},"page":"111343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In silico identification of potential inhibitors of Mycobacterium tuberculosis DNA gyrase from Phytoconstituents of Indian medicinal plants"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0161-9238","authenticated-orcid":false,"given":"Janmejaya","family":"Rout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayani","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3264-9878","authenticated-orcid":false,"given":"Sandip","family":"Kaledhonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.111343_bib2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1080\/07391102.2018.1462734","article-title":"Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13","volume":"37","author":"Cruz","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2025.111343_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jinf.2012.02.018","article-title":"Molecular epidemiology and nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus among young children attending day care centers and kindergartens in Hong Kong","volume":"64","author":"Ho","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.compbiomed.2025.111343_bib4","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.1113578109","article-title":"Patient sharing and population genetic structure of methicillin-resistant Staphylococcus aureus","volume":"109","author":"Ke","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiomed.2025.111343_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-Resistant Tuberculosis and extensively drug-resistant Tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.compbiomed.2025.111343_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13568-024-01730-3","article-title":"New insight in molecular detection of Mycobacterium tuberculosis","volume":"14","author":"Mousavi-Sagharchi","year":"2024","journal-title":"AMB Express"},{"key":"10.1016\/j.compbiomed.2025.111343_bib7","article-title":"Mycobacterium tuberculosis DNA gyrase as a target for drug discovery","volume":"7","author":"Mdluli","year":"2007","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.compbiomed.2025.111343_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012245","article-title":"Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase","volume":"5","author":"Piton","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.111343_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2025.111343_bib10","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1073\/pnas.1525055113","article-title":"Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: enhancing drug activity against wild-type and resistant gyrase","volume":"113","author":"Aldred","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiomed.2025.111343_bib11","series-title":"Tuberculosis, IntechOpen, Rijeka","article-title":"First\u2013 and second\u2013line drugs and drug resistance","author":"Nath Jnawali","year":"2013"},{"key":"10.1016\/j.compbiomed.2025.111343_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199500492-00004","article-title":"Quinolone mode of action","volume":"49","author":"Hooper","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.compbiomed.2025.111343_bib13","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.compbiomed.2025.111343_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/acsomega.1c05732","article-title":"Pharmacophore-Based virtual screening and molecular dynamics simulation for identification of a novel DNA gyrase B inhibitor with benzoxazine Acetamide scaffold","volume":"7","author":"Elseginy","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2025.111343_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.drudis.2016.11.006","article-title":"DNA topoisomerase I and DNA gyrase as targets for TB therapy","volume":"22","author":"Nagaraja","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2025.111343_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/07391102.2019.1588784","article-title":"Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: structure-based virtual screening and molecular dynamics simulations approaches","volume":"38","author":"Kalhor","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2025.111343_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijid.2021.09.028","article-title":"Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing","volume":"112","author":"Bi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.compbiomed.2025.111343_bib18","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1038\/s41598-020-65766-8","article-title":"Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species","volume":"10","author":"Ghosh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.111343_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.compbiomed.2025.111343_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1127916","article-title":"Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis","volume":"13","author":"Wu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.compbiomed.2025.111343_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jep.2005.09.024","article-title":"Integrated approaches towards drug development from Ayurveda and other Indian system of medicines","volume":"103","author":"Mukherjee","year":"2006","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.compbiomed.2025.111343_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.578970","article-title":"Indian medicinal plants and formulations and their potential against COVID-19\u2013Preclinical and clinical research","volume":"11","author":"Ahmad","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2025.111343_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.drudis.2009.05.009","article-title":"Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?","volume":"14","author":"Patwardhan","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2025.111343_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2005.07.008","article-title":"Medicinal plants: traditions of yesterday and drugs of tomorrow","volume":"27","author":"Gurib-Fakim","year":"2006","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.compbiomed.2025.111343_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrd1657","article-title":"The evolving role of natural products in drug discovery","volume":"4","author":"Koehn","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111343_bib26","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.compbiomed.2025.111343_bib27","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.bmcl.2012.02.053","article-title":"Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis","volume":"22","author":"Sureram","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiomed.2025.111343_bib28","article-title":"Screening for antimycobacterial activity of actinomycetes collected in Vietnam \u2013 isolation and activity of metabolites from Streptomyces alboniger (A121)","volume":"19","author":"Huynh","year":"2024","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.compbiomed.2025.111343_bib29","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","article-title":"Imppat 2.0: an enhanced and expanded phytochemical Atlas of Indian medicinal plants","volume":"8","author":"Vivek-Ananth","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2025.111343_bib30","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity, antimicrob","volume":"48","author":"Alexandra","year":"2004","journal-title":"Agents Chemother."},{"key":"10.1016\/j.compbiomed.2025.111343_bib31","article-title":"The molecular genetics of fluoroquinolone resistance in Mycobacterium tuberculosis, Microbiol","volume":"2","author":"Claudine","year":"2014","journal-title":"Spectr"},{"key":"10.1016\/j.compbiomed.2025.111343_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41429-025-00839-2","article-title":"Tuberculosis drug development; fluoroquinolone structural tailoring","volume":"78","author":"Guti\u00e9rrez-Mauricio","year":"2025","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.compbiomed.2025.111343_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijid.2021.11.037","article-title":"High-dose gatifloxacin-based shorter treatment regimens for MDR\/RR-TB","volume":"115","author":"Nie","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.compbiomed.2025.111343_bib34","article-title":"Gatifloxacin hydrochloride confers broad-spectrum antibacterial activity against phytopathogenic bacteria","volume":"15\u20132024","author":"Huang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.compbiomed.2025.111343_bib35","doi-asserted-by":"crossref","first-page":"33018","DOI":"10.1039\/D5RA04732C","article-title":"Gatifloxacin detection in the nanoscale: a review exploring current biosensing technologies and future opportunities","volume":"15","author":"Pious","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2025.111343_bib36","first-page":"646","article-title":"A comparative Study of Moxifloxacin Vs Gatifloxacin for preventing postoperative ocular infections after phacoemulsification","volume":"11","author":"None","year":"2025","journal-title":"J. Contemp. Clin. Pract."},{"key":"10.1016\/j.compbiomed.2025.111343_bib37","article-title":"Gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: safety, efficacy and patient perspective, Ophthalmol","volume":"4","author":"Schultz","year":"2012","journal-title":"Eye Dis"},{"key":"10.1016\/j.compbiomed.2025.111343_bib38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.str.2019.01.004","article-title":"Overall structures of Mycobacterium tuberculosis DNA gyrase reveal the role of a corynebacteriales GyrB-Specific insert in ATPase activity","volume":"27","author":"Petrella","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.compbiomed.2025.111343_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/cpps.20","article-title":"Comparative protein structure modeling using MODELLER","volume":"86","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.compbiomed.2025.111343_bib40","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib41","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2025.111343_bib43","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.111343_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.111343_bib45","author":"Sander"},{"key":"10.1016\/j.compbiomed.2025.111343_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.compbiomed.2025.111343_bib47","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib49","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2025.111343_bib50","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2025.111343_bib51","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2025.111343_bib52","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.compbiomed.2025.111343_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.compbiomed.2025.111343_bib54","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: application to microtubules and the ribosome","volume":"98","author":"Baker","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiomed.2025.111343_bib55","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2025.111343_bib56","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/07391102.2020.1819879","article-title":"In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2","volume":"40","author":"Rout","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2025.111343_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2020.105660","article-title":"Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis","volume":"195","author":"Al-Khafaji","year":"2020","journal-title":"Comput. Methods Progr. Biomed."},{"key":"10.1016\/j.compbiomed.2025.111343_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.711242","article-title":"Targeting N-Terminal human maltase-glucoamylase to unravel possible inhibitors using molecular docking, molecular dynamics simulations, and adaptive steered molecular dynamics simulations","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib59","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.91.208106","article-title":"Principal components of the protein dynamical transition","volume":"91","author":"Tournier","year":"2003","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.compbiomed.2025.111343_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1PII of original article: S0169-409X(96)00423-1","author":"Lipinski","year":"2001","journal-title":"The article was originally published in Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.compbiomed.2025.111343_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib63","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","article-title":"Physiochemical drug properties associated with in vivo toxicological outcomes","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiomed.2025.111343_bib64","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib65","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.111343_bib66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pro.3280","article-title":"Improvements to the APBS biomolecular solvation software suite","volume":"27","author":"Jurrus","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2025.111343_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2025.111343_bib68","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/med.1015","article-title":"Pharmacokinetics and its role in small molecule drug discovery research","volume":"21","author":"Jang","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.compbiomed.2025.111343_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24081505","article-title":"Lipophilicity as a central component of drug-like properties of chalchones and flavonoid derivatives","volume":"24","author":"Constantinescu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2025.111343_bib70","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.compbiomed.2025.111343_bib71","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.compbiomed.2025.111343_bib72","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.36922\/gpd.2657","article-title":"On the in silico application of the center-of-mass distance method","volume":"3","author":"Stojanov","year":"2024","journal-title":"Gene.Protein.Disease"},{"key":"10.1016\/j.compbiomed.2025.111343_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183387","article-title":"Molecular docking and dynamics simulation of protein \u03b2-Tubulin and Antifungal cyclic lipopeptides","volume":"24","author":"Cob-Calan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2025.111343_bib74","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252501697X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001048252501697X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:36:11Z","timestamp":1781166971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001048252501697X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":73,"alternative-id":["S001048252501697X"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111343","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico identification of potential inhibitors of Mycobacterium tuberculosis DNA gyrase from Phytoconstituents of Indian medicinal plants","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111343"}}